KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Bionano Genomics (BNGO) Return on Invested Capital (2018 - 2025)

Historic Return on Invested Capital for Bionano Genomics (BNGO) over the last 8 years, with Q3 2025 value amounting to 0.72%.

  • Bionano Genomics' Return on Invested Capital rose 9900.0% to 0.72% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.72%, marking a year-over-year increase of 9900.0%. This contributed to the annual value of 1.49% for FY2024, which is 2800.0% down from last year.
  • Latest data reveals that Bionano Genomics reported Return on Invested Capital of 0.72% as of Q3 2025, which was up 9900.0% from 1.43% recorded in Q2 2025.
  • Bionano Genomics' 5-year Return on Invested Capital high stood at 0.14% for Q2 2021, and its period low was 2.26% during Q4 2024.
  • For the 5-year period, Bionano Genomics' Return on Invested Capital averaged around 1.0%, with its median value being 0.65% (2023).
  • As far as peak fluctuations go, Bionano Genomics' Return on Invested Capital soared by 16200bps in 2021, and later tumbled by -16600bps in 2024.
  • Over the past 5 years, Bionano Genomics' Return on Invested Capital (Quarter) stood at 0.21% in 2021, then crashed by -137bps to 0.5% in 2022, then crashed by -290bps to 1.93% in 2023, then dropped by -17bps to 2.26% in 2024, then soared by 68bps to 0.72% in 2025.
  • Its Return on Invested Capital stands at 0.72% for Q3 2025, versus 1.43% for Q2 2025 and 1.79% for Q1 2025.